Derek Pain: Animalcare can reign with cats and dogs

No Pain, No Gain

Shares greeted 2013 in fine style. I was pleased to see that some constituents of the no-pain, no-gain portfolio joined in the New Year fun, which reflected the fact that the mighty United States economy did not, after all the posturing, tumble over the so-called fiscal cliff.

In my last column I said that investment experts were generally bullish about prospects. Indeed one eminent commentator suggested that shares could well double in the next ten years. He may be right. But such long-term predictions are, in my view, little more than shots in the dark. Indeed even the ritual of forecasting the stock market display over the next 12 months is often a hazardous and unrewarding exercise.

The stock market, although acute at anticipating events, is not a particularly good barometer of the economic and financial climates. It often swings too far, both up and down. Witness the still unconquered peak hit at the turn of the century when dotcom madness sent realistic souls rushing into shares they would normally avoid like the plague. The ragged retreat from that record level was humiliating and painful.

Still, the 2013 approach has undoubtedly been heroic. Indeed shares, with a few hiccups on the way, have made considerable headway since May and have been in particularly fine form from mid-November. I go along with those who expect the stock market to build on its positive start and enjoy a good year.

However, it is worth pointing out that the US problems have not been solved, merely kicked into the long grass. And the UK, along with many other countries, is still deep in the economic mire. A possible stock-market salvation is likely to be the poor interest rates which have undermined the savings industry. The high street rates look weak and unattractive compared with the yields (and growth prospects) that can still be obtained by investing in some blue-chips.

There are hopes that the junior AIM platform may experience a much better year. Indications that ISAs could include AIM stocks must offer encouragement. AIM has been in the dumps for some time as many investors took the view that with the banking crisis taking its toll its constituents were too speculative, and instead settled for blue-chip investments.

AIM has been around since 1995. It was created, after a couple of unsuccessful attempts, to develop a share platform for small, hopefully up-and-coming companies. I suppose it peaked in 2007 when nearly 1,700 companies enjoyed a listing on the junior market. By the end of last year membership was down to just under 1,100 with takeovers as well as graduations to full listings reducing membership. But significant factors in AIM's decline were companies retiring from the market, claiming that the cost of membership was too demanding, and a string of insolvencies.

Maybe the junior platform is over the worst. Paul Mumford of Cavendish Asset Management says he is "quite positive". But he stresses that such is the nature of the junior market that it is wise not to have too many eggs in one basket.

The portfolio has a large proportion of its membership represented by AIM stocks. One of them, Animalcare, has enjoyed a pleasing start to the year with the shares at 145p. They had been bobbing around the 132p level for some time. Cause of the advance was the group's reintroduction of a painkiller for cats and dogs called Buprecare in ampoule form.

The treatment is an important element of Animalcare's array of drugs. In the summer of 2011, the group's supplier decided to stop manufacturing Buprecare ampoules, leaving a noticeable gap in the veterinary group's coverage. Stockbroker N+1 Singer believes the shares now look good value. Analyst Chris Glasper says after a difficult time the outlook is more positive.

The portfolio is still nursing a loss. It acquired the shares at 171p. I am, of course, disappointed by their performance. But hopes the revived product, plus new lines, will help Animalcare battle what is likely to be a tough selling environment could give the stock some added momentum. Buprecare is unlikely to have an immediate impact but should help lift profits.

Independent Partners; request a free guide on NISAs from Hargreaves Lansdown

REX/Eye Candy
A photo of Charles Belk being detained by police on Friday 22 August
Alexis Sanchez celebrates after scoring his first goal for Arsenal in the Champions League qualifier against Besiktas
sportChilean's first goal for the club secures place in draw for Champions League group stages
Arts and Entertainment
Amis: 'The racial situation in the US is as bad as it’s been since the Civil War'
booksAuthor says he might come back across Atlantic after all
Life and Style
Google Doodle celebrates the 200th birthday of Irish writer Sheridan Le Fanu
Arts and Entertainment
Vinyl demand: a factory making the old-style discs
musicManufacturers are struggling to keep up with the resurgence in vinyl
In Eternal Sunshine of the Spotless Mind Jim Carrey and Kate Winslett medically erase each other from their memories
scienceTechnique successfully used to ‘reverse’ bad memories in rodents could be used on trauma victims
Arts and Entertainment
Singer Pixie Lott will take part in Strictly Come Dancing 2014, the BBC has confirmed
Finacial products from our partners
Property search
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    C# Developer (C#, ASP.NET Developer, SQL, MVC, WPF, Real-Time F

    £40000 - £48000 per annum + benefits+bonus+package: Harrington Starr: C# Devel...

    C# Swift Payment Developer (C#, ASP.NET, .NET, MVC, Authorize.N

    £45000 - £60000 per annum + benefits+bonus+package: Harrington Starr: C# Swift...

    DevOps Engineer - Linux, Shell, Bash, Solaris, UNIX, Salt-Stack

    Negotiable: Harrington Starr: A fast growing Financial Services organisation b...

    Trade Desk FIX Analyst - (FIX, SQL, Equities, Support)

    £50000 - £60000 per annum + excellent benefits: Harrington Starr: An award-win...

    Day In a Page

    Israel-Gaza conflict: No victory for Israel despite weeks of death and devastation

    Robert Fisk: No victory for Israel despite weeks of devastation

    Palestinians have won: they are still in Gaza, and Hamas is still there
    Mary Beard writes character reference for Twitter troll who called her a 'slut'

    Unlikely friends: Mary Beard and the troll who called her a ‘filthy old slut’

    The Cambridge University classicist even wrote the student a character reference
    America’s new apartheid: Prosperous white districts are choosing to break away from black cities and go it alone

    America’s new apartheid

    Prosperous white districts are choosing to break away from black cities and go it alone
    Amazon is buying Twitch for £600m - but why do people want to watch others playing Xbox?

    What is the appeal of Twitch?

    Amazon is buying the video-game-themed online streaming site for £600m - but why do people want to watch others playing Xbox?
    Tip-tapping typewriters, ripe pongs and slides in the office: Bosses are inventing surprising ways of making us work harder

    How bosses are making us work harder

    As it is revealed that one newspaper office pumps out the sound of typewriters to increase productivity, Gillian Orr explores the other devices designed to motivate staff
    Manufacturers are struggling to keep up with the resurgence in vinyl records

    Hard pressed: Resurgence in vinyl records

    As the resurgence in vinyl records continues, manufacturers and their outdated machinery are struggling to keep up with the demand
    Tony Jordan: 'I turned down the chance to research Charles Dickens for a TV series nine times ... then I found a kindred spirit'

    A tale of two writers

    Offered the chance to research Charles Dickens for a TV series, Tony Jordan turned it down. Nine times. The man behind EastEnders and Life on Mars didn’t feel right for the job. Finally, he gave in - and found an unexpected kindred spirit
    Could a later start to the school day be the most useful educational reform of all?

    Should pupils get a lie in?

    Doctors want a later start to the school day so that pupils can sleep later. Not because teenagers are lazy, explains Simon Usborne - it's all down to their circadian rhythms
    Prepare for Jewish jokes – as Jewish comedians get their own festival

    Prepare for Jewish jokes...

    ... as Jewish comedians get their own festival
    SJ Watson: 'I still can't quite believe that Before I Go to Sleep started in my head'

    A dream come true for SJ Watson

    Watson was working part time in the NHS when his debut novel, Before I Go to Sleep, became a bestseller. Now it's a Hollywood movie, too. Here he recalls the whirlwind journey from children’s ward to A-list film set
    10 best cycling bags for commuters

    10 best cycling bags for commuters

    Gear up for next week’s National Cycle to Work day with one of these practical backpacks and messenger bags
    Paul Scholes: Three at the back isn’t working yet but given time I’m hopeful Louis van Gaal can rebuild Manchester United

    Paul Scholes column

    Three at the back isn’t working yet but given time I’m hopeful Louis van Gaal can rebuild Manchester United
    Kate Bush, Hammersmith Apollo music review: A preamble, then a coup de théâtre - and suddenly the long wait felt worth it

    Kate Bush shows a voice untroubled by time

    A preamble, then a coup de théâtre - and suddenly the long wait felt worth it
    Robot sheepdog technology could be used to save people from burning buildings

    The science of herding is cracked

    Mathematical model would allow robots to be programmed to control crowds and save people from burning buildings
    Tyrant: Is the world ready for a Middle Eastern 'Dallas'?

    This tyrant doesn’t rule

    It’s billed as a Middle Eastern ‘Dallas’, so why does Fox’s new drama have a white British star?